The basic principle in the Biocidal Products Regulation ((EU) No 528/2012 (BPR)) is that a biocidal product (BP) must be authorised before it can be made available on the market or used in the European Union (EU)/ European Economic Area (EEA).
This takes place in two consecutive steps. As the first step, the active substance is evaluated and, provided the criteria are fulfilled, is then approved in a specified product-type (PT). The second step is the authorisation of each BP consisting of, containing or generating the approved active substance(s).
This document concerns the first step, approval of active substances.
October 2016
Collegati
| Descrizione | Lingua | Dimensioni | Downloads | |
|---|---|---|---|---|
 |
Abbonati Chemicals
|
EN | 5803 kB | 1 |
ID 20238 | 25.08.2023
Regolamento delegato (UE) 2023/1656 della Commissione del 16 giugno 2023 che modifica il regolam...
ECHA Novembre 2015
Questa guida fornisce informazioni su aspetti di cui tenere conto quando si compila una scheda di dati di sicurezza (...
Acrolein, Crotonaldehyde, and Arecoline
This volume of the IARC Monographs provides evaluations of the carcinogenicity of three chemicals: acrolein, crotonaldehyde, and arecol...
Testata editoriale iscritta al n. 22/2024 del registro periodici della cancelleria del Tribunale di Perugia in data 19.11.2024